Literature DB >> 29340464

Seroprevalence of human Trypanosoma cruzi infection in the North of Estado de Mexico.

Saúl González-Guzmán1,2, Sergio Pichardo-Ávila3, Eulalia Mimbrera-Rodríguez3, José Antonio Crescencio-Trujillo4, María de Lourdes Gasca-Leyva5, Fernando Martínez-Hernández6, Nancy Rivas7, Ricardo Alejandre-Aguilar7.   

Abstract

INTRODUCTION: Chagas disease is a neglected public health problem in Mexico; however, detailed studies to determine the seroprevalence in some states have not been performed.
METHODS: A total 1,504 human serum from thirteen communities in Estado de Mexico, were analyzed with three diagnostics techniques.
RESULTS: The overall seroprevalence was 9.1%, with high prevalence among people aged 51-60 years, while people aged 0-29 years were seronegative against T. cruzi.
CONCLUSIONS: Our data demonstrated the seroprevalence of T. cruzi in the North of the Estado de Mexico, an area considered as non-endemic; however, epidemiological conditions necessary for natural transmission were found.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29340464     DOI: 10.1590/0037-8682-0512-2016

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  2 in total

Review 1.  Updated Estimates and Mapping for Prevalence of Chagas Disease among Adults, United States.

Authors:  Amanda Irish; Jeffrey D Whitman; Eva H Clark; Rachel Marcus; Caryn Bern
Journal:  Emerg Infect Dis       Date:  2022-07       Impact factor: 16.126

2.  Has the prevalence of Chagas disease increased in Central Latin America?

Authors:  Kota Yoshioka; Ken Hashimoto; Carlota Monroy
Journal:  PLoS Negl Trop Dis       Date:  2020-12-03
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.